ストックスクリーナーアプリを入手
7.375
0.41%
-0.025
Amicus Therapeutics Inc (FOLD) 最新ニュース
Amicus Therapeutics (FOLD) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
Rock Springs Capital Management LP Purchases 1,349,145 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Jump Financial LLC Lowers Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Amicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Is Amicus Therapeutics, Inc. (FOLD) Among the Best Guru Stocks to Buy According to Wall Street Analysts? - Yahoo Finance
Amicus Therapeutics to Report Q1 Earnings: What's in the Cards? - Yahoo Finance
11 Best Guru Stocks to Buy According to Wall Street Analysts - Insider Monkey
Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025 | FOLD Stock News - GuruFocus
Amicus Therapeutics to Announce First Quarter 2025 Financial Results on May 1, 2025 - GlobeNewswire
Pompe Disease Therapeutic Market Projected To Witness - openPR.com
Granite Investment Partners LLC Purchases 166,657 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Renaissance Technologies LLC Has $19.86 Million Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
4 Healthcare Stocks to Buy as the Sector Faces Government Heat - Yahoo Finance
(FOLD) Proactive Strategies - news.stocktradersdaily.com
Pompe Disease Treatment Market New Product Development & Latest Trends | Sanofi,Amicus Therapeutics,Genzym - openPR.com
Enzyme Replacement Therapy Market Is Booming Worldwide - openPR.com
Amicus Therapeutics (NASDAQ:FOLD) Shares Down 6.3%Should You Sell? - MarketBeat
Amicus Therapeutics (NASDAQ:FOLD) Sets New 52-Week LowHere's What Happened - MarketBeat
Norges Bank Invests $29.03 Million in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Is Amicus Therapeutics, Inc. (FOLD) the Best Low Priced Growth Stock To Invest In? - Insider Monkey
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Not Doing Enough For Some Investors As Its Shares Slump 27% - simplywall.st
ExodusPoint Capital Management LP Trims Stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Massachusetts Financial Services Co. MA Grows Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Fabry Disease Treatment Market Opportunity and Forecast Report 2025-2034 Featuring Amicus Therapeutics, Avrobio, Freeline, Idorsia, ISU Abxis, JCR, Novartis, Pfizer, Protalix, Sanofi, Takeda, Viatris - Yahoo Finance
Analysts Expect Amicus Therapeutics, Inc. (NASDAQ:FOLD) To Breakeven Soon - Yahoo Finance
Vanguard Group Inc. Has $275.62 Million Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
JPMorgan Chase & Co. Reduces Stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Amicus Therapeutics stock hits 52-week low at $6.99 By Investing.com - Investing.com South Africa
Amicus Therapeutics stock hits 52-week low at $6.99 - Investing.com
Is Amicus Therapeutics, Inc. (FOLD) the Best Low Cost Stock to Buy According to Billionaires? - Insider Monkey
What is Zacks Research's Estimate for FOLD Q1 Earnings? - MarketBeat
Trexquant Investment LP Acquires 486,827 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
AMICUS STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Amicus Therapeutics, Inc. - Bluefield Daily Telegraph
AMICUS STOCKHOLDER ALERT: Kaskela Law LLC Announces - GlobeNewswire
Old West Investment Management LLC Raises Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
Zacks Research Analysts Increase Earnings Estimates for FOLD - MarketBeat
Pictet Asset Management Holding SA Sells 110,241 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat
0.63%
大文字化:
|
ボリューム (24 時間):